Sana Biotechnology, Inc. announced that Brian Piper will serve as Executive Vice President and Chief Financial Officer, effective February 17, 2026. Piper joins the company’s senior leadership team after a career that has included senior finance roles at several biotechnology firms, positioning him to strengthen Sana’s financial planning, investor relations, and capital‑raising capabilities as the company advances its metabolic disease pipeline.
Continue reading for full analysis...